Skip to content
Operating

Investment Income Net Amortization Of Discount And Premium

Moderna Investment Income Net Amortization Of Discount And Premium decreased by 15.4% to $11M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 42.1%, from $19M to $11M. Over 3 years (FY 2021 to FY 2025), Investment Income Net Amortization Of Discount And Premium shows an upward trend with a 7.5% CAGR.

Analysis

StatementCash Flow Statement
SectionOperating
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
Metric ID: operating_investment_income_net_amortization_of_discount_b68ca1

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$8M-$20M-$21M-$18M-$11M-$6M$17M$12M$12M$20M$27M$28M$21M$19M$19M$18M$17M$13M$11M
QoQ Change-150.0%-5.0%+14.3%+38.9%+45.5%+383.3%-29.4%+0.0%+66.7%+35.0%+3.7%-25.0%-9.5%+0.0%-5.3%-5.6%-23.5%-15.4%
YoY Change-37.5%+70.0%+194.4%+209.1%+300.0%+58.8%+133.3%+75.0%-5.0%-29.6%-35.7%-19.0%-31.6%-42.1%
Range-$21M$28M
CAGR+7.3%
Avg YoY Growth+60.0%
Median YoY Growth+26.9%
Current Streak4 quarters decline

Frequently Asked Questions

What is Moderna's investment income net amortization of discount and premium?
Moderna (MRNA) reported investment income net amortization of discount and premium of $11M in Q1 2026.
How has Moderna's investment income net amortization of discount and premium changed year-over-year?
Moderna's investment income net amortization of discount and premium decreased by 42.1% year-over-year, from $19M to $11M.
What is the long-term trend for Moderna's investment income net amortization of discount and premium?
Over 3 years (2021 to 2025), Moderna's investment income net amortization of discount and premium has grown at a 7.5% compound annual growth rate (CAGR), from -$54M to $67M.